pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2h ago·1 min read
save

Researchers create mouse with human-derived brain cortex, sparking ethical and scientific debate

Sep 30, 2026·read at STAT ↗Neutral

A research team led by Stanford professor Sergiu Pașca has reported in Nature the creation of a laboratory mouse whose cerebral cortex is built from human brain cells derived from stem cells. The study describes how the human-derived cortex integrates with the mouse brain architecture.

The development is notable because the human cortex underlies many aspects of complex cognition. Scientists hope the hybrid model will provide a new platform for investigating human brain development, neurological disorders, and drug testing in a living system.

The work has prompted ethical reflection, with the author comparing the scenario to fictional stories such as "Flowers for Algernon" and the cartoon "Pinky and the Brain." The prospect of a mouse possessing a substantially human brain region raises questions about consciousness and animal welfare.

The commentary appears in an opinion column by Paul Knoepfler, a UC Davis professor, and is available to STAT+ subscribers.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: STAT+: What to think about those mice with half-human brains”

read at STAT ↗
424 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
UNIQUEUltragenyx Pharmaceutical Inc.
topics
CardiologyNeurologyRare Disease

related stories

  • 6d agoNovo workforce down 13,000BioSpace
  • Sep 17Chutes & Ladders—Legend poaches Novartis vet to boost commercial potentialFierce Biotech
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Jun 6Opinion: How the Amish think about vaccines, health care costs, and much moreSTAT
  • Sep 14Psychedelic therapies ride wave of public favor into FDA hearingBioSpace